Shortness of breath

Published on 10/02/2015 by admin

Filed under Emergency Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2603 times

Chapter 4 Shortness of breath

Primary survey positive patients

Recognition

Patients with a life threatening respiratory emergency will present in either respiratory failure or respiratory distress. Patients with respiratory distress are still able to compensate for the effects of their illness, and urgent treatment may prevent their further deterioration. They present with signs and symptoms indicating increased work of breathing but findings suggesting systemic effects of hypoxia or hypercapnia will be limited or absent. Conversely, patients with respiratory failure may have limited evidence of increased work of breathing as they become too exhausted to compensate. The systemic effects of hypoxia and hypercapnia will be particularly evident in this group and immediate treatment will be required to prevent cardiac arrest. The key findings of primary survey positive patients with shortness of breath are presented in Box 4.3.

Treatment

If it is not possible to obtain an airway, if the patient’s condition is deteriorating rapidly, or they show signs of significant respiratory failure (in particular failure to maintain SpO2 of 95% on high concentration oxygen) consider immediate transportation to a hospital with appropriate facilities. Important treatment points for primary survey positive patients are listed in Box 4.4.

Secondary survey

The SOAPC system should be used to undertake a secondary survey (see Chapter 2). In primary survey positive patients, a secondary survey may not be completed in the pre-hospital phase of treatment as the focus must be on treatment of life threatening problems. For primary survey negative patients requiring hospital care the secondary survey may be undertaken during transportation. For the remaining patient population a secondary survey may be undertaken at the point of contact and will contribute to the decision to admit, treat and refer, or treat and leave.

Objective examination

General examination

Look for signs of the ‘unwell’ patient (see Chapter 2). A detailed examination of the respiratory system is mandatory for patients with shortness of breath. Remember, however, that myocardial infarction, acute coronary syndromes and congestive cardiac failure can also result in respiratory distress, as may endocrine and neurological problems (for example Kussmaul’s and Cheyne–Stokes respiration in hyperglycaemia and raised intra-cranial pressure respectively). If a respiratory problem cannot be readily identified as the cause of the patient’s symptoms, undertake an examination of the other systems.

For details of the respiratory examination, refer to Boxes 4.3, 4.5, 4.6 and 4.7 and to Chapter 2. Note if the patient has excessive production of sputum. What colour is this? Yellow, green or brown sputum indicates a chest infection. White frothy sputum, which may also be tinged with pink, suggests pulmonary oedema.

Look at the patient to determine their colour, and for signs of raised jugular venous pressure. Is the patient breathing through pursed lips, or using accessory muscles, perhaps suggesting COPD? Are there signs of CO2 retention (tremor of the hands, facial flushing, falling conscious level)? Palpate the trachea to check that it is in the midline. Examine the chest and observe chest expansion. Is this the same on both sides? Is there evidence of hyperinflation? Are scars present from surgery? Is there evidence of chest wall deformity?

Feel the chest to confirm equality of movement, and check for chest wall crepitus and surgical emphysema. Is there evidence of chest wall tenderness or pain? Is any pain positional, or worsened on inspiration (as, for example, in pleurisy)? Feel for tactile vocal fremitus (TVF). This is assessed by placing the side of a hand on both sides of the chest in the anterior and posterior upper, middle, and lower zones and asking the patient to say ‘ninety-nine’. The resulting low-frequency sounds should normally be palpable, and transmission should be compared for symmetry and differences between the areas assessed.

Listen to the chest. Percuss the anterior and posterior chest wall bilaterally at the top, middle and bottom of the back. Is the percussion note normal, dull or hyper-resonant? Auscultate the chest at the same locations and in the axillae while the patient breathes in and out of an open mouth. Listen for the sounds of bronchial breathing, wheeze or crackles. Listen for vocal resonance and pleural rubs. Vocal resonance is assessed by asking the patient to whisper ‘one, two, three’ and listening with a stethoscope in the areas described for assessing TVF. Some resonance (although not the words themselves) should normally be detected and differences between areas should be noted as described above. Increased sound transmission, demonstrated by clear detection of words spoken by the patient and known as whispering pectoriloquy, is abnormal. Both TVF and vocal resonance are used to assess for the presence of consolidation (increased resonance) or pneumothorax or pleural effusion (decreased resonance).

If the adult patient complains of symptoms of a respiratory tract infection, undertake an ENT examination. Look in the mouth to examine for tonsillar and pharyngeal inflammation, and feel for enlargement of the lymph nodes in the neck.

In all patients with sudden onset of shortness of breath and in the absence of other findings strongly suggestive of a respiratory problem, undertake an examination of the cardiovascular system (see Chapters 2 and 3).

The pertinent features of the respiratory examination are summarised in Box 4.7.

Analysis (differential diagnosis)

Diagnosis is often straightforward with a typical history and findings. For example the patient presenting with wheeze and tachypnoea may state that they have asthma. The skill is in determining the severity of the condition. Few patients die due to the misdiagnosis of asthma but significant numbers die because professionals or patients under-estimate the severity of an attack. Differential diagnosis can also be very difficult, classically in distinguishing between an exacerbation of COPD and cardiogenic pulmonary oedema. This may be made simpler by the use of b-naturetic peptide (BNP) estimations. This has recently been made available as a near-patient test and may become increasingly common in the out-of-hospital setting.

Asthma

The pointers in history and examination in patients with asthma that help to gauge the severity of an attack are summarised in Table 4.1. Patients with severe or life threatening asthma need calm reassurance (even if the healthcare provider is personally anxious), early treatment with beta-2 agonists, oxygen and immediate transfer to hospital. Patients with mild or moderate attacks who respond well to treatment may be suitable for home management with further inhaled beta-2 agonists, oral steroids and early review (Box 4.8 and Table 4.1).1

COPD

Exacerbations of COPD are common. These can be triggered by a number of factors but a viral infection is the most frequent. Diagnosis is often simple but it is the assessment of the severity of the condition that needs skill. The main differential diagnosis is of cardiogenic pulmonary oedema (LVF). A pneumothorax is an uncommon reason for a severe sudden exacerbation of COPD. Knowledge of the patient’s normal pulmonary function is important. Some patients with COPD have a ‘normal’ PO2 that would indicate severe respiratory failure in a normal individual. Signs of exhaustion, inability to expectorate or CO2 retention are the main worrying features indicating a severe attack.

Oxygen treatment in these patients should be titrated against the SpO2 (controlled oxygen therapy – see the North-West Oxygen Group guidelines2). If the attack is not severe and the patient has adequate home support, then hospital admission may be avoided (Box 4.9).3

Acute cardiogenic pulmonary oedema

The onset is often sudden and severe. The patient is older and usually has a history of ischaemic heart disease although this may be the first indication of heart problems. Acute MI is often a precipitating factor. Severe shortness of breath, white frothy sputum, tachypnoea, tachycardia, pallor and sweating are common. Such patients need to be transported to hospital, sitting upright if possible. Immediate treatment consists of buccal nitrates (providing the blood pressure is not low), oxygen and intravenous opiates (Box 4.10).

Conditions for exclusion if hospital attendance is not considered appropriate

Box 4.5 lists the key findings that indicate the need for immediate hospital admission in primary survey negative patients. Table 4.2 describes additional findings determined from the secondary survey that will suggest the need for hospital admission. In asthma or COPD, failure to respond to the initial dose of a beta-2 agonist (e.g. nebulised salbutamol) is also an indication for considering hospitalisation, as is a history of a previous near-fatal attack – regardless of the severity of the current episode. All patients with a first episode of pulmonary oedema or an acute exacerbation of a chronic problem should be admitted to hospital for further investigation and treatment.

Pneumothorax

Spontaneous pneumothorax is most common in tall, thin, fit young men (Table 4.2). It is an uncommon complication of asthma and COPD. There are some rarer causes but these are very uncommon in the community setting. If a pneumothorax is suspected the patient will need to be referred to hospital for an X-ray and further evaluation.

Table 4.2 Findings from secondary survey suggesting need for hospital admission

Condition Key findings
Pleural effusion History of cancer, cardiac failure or renal failure
Limited chest expansion on the affected side
Dull percussion note over the affected area
Reduced breath sounds, TVF and vocal resonance over the affected area
Possible pleuritic rub (infection)
Tracheal shift away from the effusion (late sign)
Pneumothorax (most spontaneous pneumothoraces occur in tall, thin, fit young adults) Sudden onset of dyspnoea and pleuritic chest pain (early sign) Development of tension pneumothorax may be identified by increasing dyspnoea, and:
Reduced chest expansion on the affected side
Hyper-inflated, fixed chest wall on the affected side Surgical emphysema (rare)
Trachea deviated away from affected side
Chest hyper-resonant to percussion
Decreased or absent breath sounds on the affected side
Raised JVP
Deteriorating cardiovascular status (late sign)
Lung collapse (bronchial obstruction) Dyspnoea Reduced chest expansion on affected side Tracheal deviation towards side of collapse Dull to percussion over non-inflated area Decreased TVF over affected area Breath sounds absent or decreased over affected area; increased bronchial breathing elsewhere
Pulmonary embolism (PE) Clinical features compatible with PE:
(a) Dyspnoea and/or (b) Tachypnoea (> 20 breaths per minute) and
(c) Haemoptysis and/or
(d) Pleuritic chest pain Major risk factors for PE:
(a) Major abdominal or pelvic surgery
(b) Hip or knee replacement
(c) Post-operative intensive care
(d) Late pregnancy
(e) Caesarean section
(f) Puerperium
(g) Lower limb fracture
(h) Varicose veins
(i) Abdominal, pelvic, or metastatic malignancy
(j) Reduced mobility due to hospitalisation or institutional care
(k) Previous history of venous thromboembolism In the absence of another reasonable clinical explanation for the signs and symptoms:
If (a), (b) and (c) are all confirmed the likelihood of PE is high;
If (a) and (b) or (c) are present the likelihood of PE is intermediate; If (a) is present but (b) and (c) are both absent the likelihood of PE is low, especially in cases of pleuritic chest pain or haemoptysis not accompanied by breathlessness

Treatment and disposal (plan)

The initial out-of-hospital treatment of each of the four key conditions is given in Table 4.3 and Boxes 4.12 to 4.14. Interventions recommended in the JRCALC guidelines for paramedic use are asterisked.6

Table 4.3 Treatment of asthma2

Moderate acute asthma Severe acute asthma (or no response to treatment in moderate asthma) Life threatening acute asthma
Protect and maintain airway as necessary Oxygen via non-rebreathing mask* Oxygen via non-rebreathing mask*
Position for comfort (usually sitting upright) Give salbutamol 5 mg nebuliser* Give salbutamol 5 mg nebuliser mixed with ipratropium 0.5 mg*
Salbutamol 5 mg via oxygen driven nebuliser Administer prednisolone 40–50 mg orally or hydrocortisone 100 mg IV* Commence transportation to hospital
If PEFR >50–75% of normal, give prednisolone 40–50 mg orally If no response, give salbutamol 5 mg nebuliser mixed with ipratropium 0.5 mg* Administer prednisolone 40–50 mg orally or hydrocortisone 200 mg IV*
Treat and leave if patient responds to treatment Give continuous salbutamol 5 mg nebulisers until symptoms are controlled Give continuous salbutamol 5 mg nebulisers until symptoms are controlled
Arrange re-assessment, possibly by telephone, at a suitable time Consider treat and leave if patient fully responds to treatment and has adequate carer support Consider intravenous crystalloids in the presence of dehydration to limit mucous plugging
Consider referring to GP or specialist nurse for delayed follow-up if patient requires further support or review of treatment If discharged, arrange re-assessment, possibly by telephone, at a suitable time Refer to GP for immediate appointment

Disposition flow chart

Figure 4.2 describes the decision-making process for patient disposition.